A comparison between the effects of Hip Flexion Assist Orthosis and conventional Ankle Foot Orthosis on walking in multiple sclerosis patients

A comparison between the immediate effects of Hip Flexion Assist Orthosis and conventional Ankle Foot Orthosis on gait parameters in ambulatory multiple sclerosis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201206295520N7

Enrollment

Registered

2012-09-17

Start date

2012-09-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis. Multiple sclerosis

Interventions

Intervention 1: Hip Flexion Assist Orthosis. Intervention 2: Conventional Ankle Foot Orthosis.

Rehabilitation

Hip Flexion Assist Orthosis

Conventional Ankle Foot Orthosis

Eligibility

Sex/Gender

All

Age

20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Acquiring 2 or 3 points in HA; Age between 20-45 years; Unilateral weakness in lower limb (flexor muscles); Ability of walking without any assistive devices for 2 minutes. Exclusion criteria: No pain; Any open wounds in waist area; Spasticity in the lower extremities; Any obvious deformity in the lower extremities.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Velocity. Timepoint: Just before the intervention and after 5 minutes. Method of measurement: 2MWT.;Satisfaction. Timepoint: After the interventions. Method of measurement: using the satisfaction questionnaire.;Symmetry of walking. Timepoint: Just before the intervention and after 5 minutes. Method of measurement: Using Symetry Index.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMojtaba Kamyab

Tehran University of Medical Sciences, School of Rehabilitation.

m-kamyab@tums.ac.ir+98 21 2222 8051

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026